Mr. Mark Upsdell reports

RAPID DOSE THERAPEUTICS BEGINS TRADING ON THE OTCQB IN THE UNITED STATES UNDER SYMBOL RDTCF, EXPANDING ACCESS FOR U.S. HEALTHCARE AND BIOTECHNOLOGY INVESTORS

Rapid Dose Therapeutics Corp.'s common shares are now trading in the United States on the OTCQB Venture Market under the ticker symbol RDTCF.

The OTCQB listing expands Rapid Dose Therapeutics' presence in the U.S. capital markets by increasing accessibility and visibility for American investors while providing direct access to the company's shares, enhancing liquidity, broadening market participation and strengthening engagement with the North American life sciences investment community.

"Trading on the OTCQB strengthens our visibility with U.S. investors and aligns with our long-term strategy to support growth, partnerships and commercialization across multiple verticals," said Mark Upsdell, chief executive officer of Rapid Dose Therapeutics. "With growing demand for innovative drug delivery systems and our expanding QuickStrip oral thin-film portfolio, this milestone positions Rapid Dose Therapeutics for accelerated growth and long-term shareholder value."

The company's flagship product QuickStrip is a rapidly dissolving oral thin film that delivers a controlled dose of active ingredients through sublingual or buccal absorption, offering a reliable, discreet and easy-to-use method of administration.

The OTCQB Venture Market, operated by OTC Markets Group, is designed for growth-stage and emerging companies that maintain transparent financial reporting and meet continuing compliance standards, providing investors with greater confidence and market integrity.

Rapid Dose Therapeutics will continue trading in Canada on the Canadian Securities Exchange under the symbol DOSE.

About Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient.

We seek Safe Harbor.